Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...
Saved in:
Main Authors: | M Teixeira (Author), P Rodrigues-Santos (Author), P Garrido (Author), E Costa (Author), B Parada (Author), J Sereno (Author), R Alves (Author), L Belo (Author), F Teixeira (Author), A Santos-Silva (Author), F Reis (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
by: Moon Sun Kim, et al.
Published: (2010) -
Resistance to recombinant human erythropoietin therapy in haemodialysis patients
by: Elísio Costa, et al.
Published: (2009) -
Nicorandil Improves Glomerular Injury in Rats With Mesangioproliferative Glomerulonephritis via Inhibition of Proproliferative and Profibrotic Growth Factors
by: Hirokazu Sudo, et al.
Published: (2009) -
CORRECTION OF ISCHEMIC DAMAGE TO THE RETINA ON APPLICATION OF PHARMACOLOGICAL PRECONDITIONING OF RECOMBINANT ERYTHROPOIETIN
by: Anna Shabelnikova
Published: (2016) -
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010)